abstract |
The present invention relates to a pharmaceutical composition comprising a monodafinyl compound in solution. Preferably, the composition comprises an aqueous solvent and at least one organic solvent. The present invention also relates to the use of a modafinil compound or the above composition for use in the treatment of diseases such as sleepiness, fatigue, Parkinson's disease, cerebral ischemia, stroke, sleep apnea. SHE |